ASHLI BROOKS: Open Payments
NPI 1417102146 · PANAMA CITY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,123 in 49 payments from 18 companies in 2025. Trend: 2023 $1,695 · 2024 $1,022 · 2025 $1,123
Food & beverage: $1,033Education: $90
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 11 | $264 |
| Novo Nordisk Inc | 9 | $144 |
| Astellas Pharma US Inc | 3 | $128 |
| Dexcom, Inc. | 4 | $105 |
| Amgen Inc. | 3 | $61 |
| Ascendis Pharma Endocrinology Inc | 3 | $58 |
| Corcept Therapeutics | 1 | $49 |
| BETA BIONICS, INC. | 2 | $49 |
| ABBVIE INC. | 3 | $47 |
| Abbott Laboratories | 2 | $45 |
Products named: MINIMED 780G, Dexcom G6 Transmitter, Ozempic, INCEPTIV, Yorvipath, Korlym, iLet Bionic Pancreas, TEPEZZA.
Industry payments across FL — which companies pay providers there.
